Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) EPS (Basic): 2021-2024

Historic EPS (Basic) for Immunocore Holdings (IMCR) over the last 4 years, with Dec 2024 value amounting to -$1.02.

  • Immunocore Holdings' EPS (Basic) fell 102.29% to -$0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.57, marking a year-over-year increase of 39.59%. This contributed to the annual value of -$1.02 for FY2024, which is 9.73% up from last year.
  • Latest data reveals that Immunocore Holdings reported EPS (Basic) of -$1.02 as of FY2024, which was up 9.73% from -$1.13 recorded in FY2023.
  • Immunocore Holdings' EPS (Basic)'s 5-year high stood at -$1.02 during FY2024, with a 5-year trough of -$4.24 in FY2021.
  • Over the past 3 years, Immunocore Holdings' median EPS (Basic) value was -$1.13 (recorded in 2023), while the average stood at -$1.10.
  • Data for Immunocore Holdings' EPS (Basic) shows a peak YoY surged of 72.88% (in 2022) over the last 5 years.
  • Immunocore Holdings' EPS (Basic) (Yearly) stood at -$4.24 in 2021, then skyrocketed by 72.88% to -$1.15 in 2022, then increased by 1.74% to -$1.13 in 2023, then rose by 9.73% to -$1.02 in 2024.